DuPont (DD) Launches AmberChrom SIL Silica Gel For Peptide Purification

DuPont de Nemours (NYSE:DD) introduced its AmberChrom SIL silica gel for peptide purification, expanding its bioprocessing portfolio. The AmberChrom SIL product is aimed at purification of peptide therapeutics used in treatments for diabetes, obesity, and oncology. The technology is designed to deliver high resolution, stability, and scalability while fitting into existing chromatography setups for manufacturers. AmberChrom SIL silica gel broadens DuPont's peptide purification reach, yet...